Thyroid function in breast cancer patients

N Ditsch, S Liebhardt, F Von Koch, M Lenhard… - Anticancer …, 2010 - ar.iiarjournals.org
Background: Recent studies indicate a possible relationship between hypothyroidism and
breast cancer in vivo. In addition, oestrogen-like effects of thyroid hormones on breast …

The molecular function and clinical role of thyroid stimulating hormone receptor in cancer cells

YD Chu, CT Yeh - Cells, 2020 - mdpi.com
The thyroid stimulating hormone (TSH) and its cognate receptor (TSHR) are of crucial
importance for thyrocytes to proliferate and exert their functions. Although TSHR is …

American Association of Clinical Endocrinologists and American College of Endocrinology disease state clinical review: the increasing incidence of thyroid cancer

L Davies, LGT Morris, M Haymart, AY Chen… - Endocrine Practice, 2015 - Elsevier
ABSTRACT Objective:(1) Describe current epidemiology of thyroid cancer in the United
States;(2) evaluate hypothesized causes of the increased incidence of thyroid cancer; and …

Association of radioactive iodine, antithyroid drug, and surgical treatments with solid cancer mortality in patients with hyperthyroidism

CM Kitahara, DL Preston, JA Sosa… - JAMA Network …, 2020 - jamanetwork.com
Importance The long-term health effects of radioactive iodine (RAI) and antithyroid drug
(ATD) treatments compared with surgery for hyperthyroidism remain uncertain. Objective To …

Effects of thyroid hormone suppression therapy on adverse clinical outcomes in thyroid cancer

NJ McGriff, G Csako, L Gourgiotis, LC Guthrie… - Annals of …, 2002 - Taylor & Francis
BACKGROUND. Long-term thyroid hormone (TH) therapy aiming at the suppression of
serum thyrotropin (TSH) has been traditionally used in the management of well differentiated …

Cancer incidence and mortality in patients treated either with RAI or thyroidectomy for hyperthyroidism

E Ryödi, S Metso, P Jaatinen, H Huhtala… - The Journal of …, 2015 - academic.oup.com
Context: Some previous studies have suggested increased cancer risk in hyperthyroid
patients treated with radioactive iodine (RAI). It is unclear whether the excess cancer risk is …

[HTML][HTML] Thyroid cancer

K Lee, C Anastasopoulou, C Chandran… - StatPearls …, 2023 - ncbi.nlm.nih.gov
Objectives: Outline the epidemiology and risk factors of thyroid cancer. Describe the clinical
presentation and detailed histopathology of the different types of thyroid cancer. Explain the …

Associations of serum thyrotropin concentrations with recurrence and death in differentiated thyroid cancer

GC Hovens, MP Stokkel, J Kievit… - The Journal of …, 2007 - academic.oup.com
Objective: The relation between serum TSH levels and risk for recurrence or thyroid
carcinoma-related death in patients with differentiated thyroid carcinoma has only been …

Thyroid cancer, recent advances in diagnosis and therapy

F Nabhan, PH Dedhia… - International journal of …, 2021 - Wiley Online Library
Over the past several decades, the approach to the diagnosis and management of patients
with follicular cell‐derived thyroid cancer has evolved based on improved classification of …

Bone mineral density in well‐differentiated thyroid cancer patients treated with suppressive thyroxine: a systematic overview of the literature

ML Quan, JL Pasieka, O Rorstad - Journal of surgical oncology, 2002 - Wiley Online Library
Background The effects of subclinical hyperthyroidism on bone mineral density (BMD)
induced by suppressive thyroxine therapy in patients with well‐differentiated thyroid cancer …